The invention relates to compositions comprising IGFBP-3 receptor agonist monoclonal antibodies and methods for the treatment of cancers, metabolic syndrome, obstructive respiratory disorders and related diseases with IGFBP-3 receptor agonist monoclonal antibodies.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Ready to Market
Technology Readiness Level: TRL 5
Organization Type: Academic/Gov Lab
GOVT/EXTERNAL FUNDING SOURCES